This vaccine is now in clinical trial in Germany, for newly diagnosed IDH1-mutant high grade glioma.https://www.clinicaltrials.gov/ct2/show/NCT02454634At trial at Duke for recurrent grade 2 glioma not yet recruiting.https://clinicaltrials.gov/ct2/show/NCT02193347
This vaccine is now in clinical trial in Germany, for newly diagnosed IDH1-mutant high grade glioma.
ReplyDeletehttps://www.clinicaltrials.gov/ct2/show/NCT02454634
At trial at Duke for recurrent grade 2 glioma not yet recruiting.
https://clinicaltrials.gov/ct2/show/NCT02193347